DGNOF Stock, Diagnos Inc Information

Founded in , DIAGNOS is a publicly traded Canadian corporation with a mission of early detection of critical health issues through the use of its Artificial Intelligence AI tool CARA Computer Assisted Retina Analysis . CARA is a tele ophthalmology platform that integrates with existing equipment hardware and software and processes at the point of care POC . CARA s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer, and easier to read. CARA is accessible securely over the internet, and is compatible with all recognized image formats and brands of fundus cameras, and is EMR compatible. CARA is a cost effective tool for screening large numbers of patients, in real time and has been approved by regulatory authorities including Health Canada, US Food and Drug Administration, the European Union and in Mexico.